Submit manuscript...
Journal of
eISSN: 2572-8466

Applied Biotechnology & Bioengineering

Review Article Volume 12 Issue 4

Congenital diaphragmatic hernia: current repair strategies and future directions in treatment

Russ, Kiersten, Tawil Bill

Received: June 27, 2025 | Published: July 18, 2025

Citation: Russ, Kiersten, Bill T. Congenital diaphragmatic hernia: current repair strategies and future directions in treatment. J Appl Biotechnol Bioeng 2025;12(3):144-150. DOI: 10.15406/jabb.2025.12.00396

Download PDF

Abstract

Congenital diaphragmatic hernia (CDH) is a serious and life-threatening birth defect caused by malformation of the diaphragm, allowing abdominal organs to herniate into the thoracic cavity and compress the lungs. While minor cases can be corrected surgically, large and complex defects require synthetic or biological patch repair. Synthetic materials like expanded polytetrafluoroethylene (ePTFE) offer high mechanical strength but suffer from poor tissue integration and increased infection risk. Biological scaffolds offer biocompatibility and potential for remodeling but often lack mechanical durability. This paper reviews the current landscape of CDH treatment, including patch materials in clinical use, market trends, and emerging innovations in biomaterials that seek to overcome existing limitations.

Keywords: congenital diaphragmatic hernia, patch repair, tissue engineering, biomaterials

Creative Commons Attribution License

©2025 Russ,, et al. This is an open access article distributed under the terms of the, which permits unrestricted use, distribution, and build upon your work non-commercially.